CN Patent

CN114599657B — Cftr调节剂的结晶形式

Assigned to Vertex Pharmaceuticals Inc · Expires 2024-10-11 · 2y expired

What this patent protects

本发明公开了式(I)的化合物I的结晶形式，其药学上可接受的盐以及其溶剂化物和水合物。还公开了包含其的药物组合物、使用其治疗囊性纤维化的方法以及其制备方法。

USPTO Abstract

本发明公开了式(I)的化合物I的结晶形式，其药学上可接受的盐以及其溶剂化物和水合物。还公开了包含其的药物组合物、使用其治疗囊性纤维化的方法以及其制备方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN114599657B
Jurisdiction: CN
Classification: —
Expires: 2024-10-11
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.